RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Lymphatic Metastasis
Accession: DOID:9000081
browse the term
Definition: Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.
Synonyms: exact_synonym: Lymphatic Metastases
narrow_synonym: lymph node metastatic carcinoma
primary_id: MESH:D008207 ; RDO:0006041
xref: EFO:0004906 ; EFO:1001364
G
Abca13
ATP-binding cassette, sub-family A member 13
susceptibility
ISO
DNA:amplification:cds: (human, male)
RGD
PMID:27366209
RGD:152995256
NCBI chr11:9,141,942...9,634,871
Ensembl chr11:9,141,942...9,634,259
G
Adam28
a disintegrin and metallopeptidase domain 28
ISO
associated with breast cancer;DNA:hypermethylation:
RGD
PMID:25620615
RGD:153298970
NCBI chr14:68,842,447...68,893,338
Ensembl chr14:68,843,476...68,893,291
G
Adgrb1
adhesion G protein-coupled receptor B1
disease_progression
ISO
associated with stomach cancer;
RGD
PMID:11172604
RGD:13831357
NCBI chr15:74,388,045...74,461,314
Ensembl chr15:74,388,044...74,461,314
G
Aicda
activation-induced cytidine deaminase
ISO
associated with stomach cancer;protein:increased expression:stomach (human)
RGD
PMID:21538122
RGD:127285638
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
G
Angptl4
angiopoietin-like 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17130448
NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
G
Anxa1
annexin A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
G
Aqp3
aquaporin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21401805
NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183
G
Arhgap5
Rho GTPase activating protein 5
ISO
associated with nasopharynx carcinoma;mRNA, protein:increased expression: epithelium of nasopharynx
RGD
PMID:25961434
RGD:11056278
NCBI chr12:52,550,555...52,618,761
Ensembl chr12:52,550,755...52,618,758
G
Asxl1
ASXL transcriptional regulator 1
ISO
associated with colorectal cancer
RGD
PMID:32317519
RGD:126779580
NCBI chr 2:153,187,750...153,245,927
Ensembl chr 2:153,187,749...153,245,927
G
Axl
AXL receptor tyrosine kinase
ISO
associated Pancreatic Neoplasms
RGD
PMID:19252414
RGD:2325833
NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
G
Bag1
BCL2-associated athanogene 1
disease_progression
ISO
associated with Breast Neoplasms:protein:increased expression:breast
RGD
PMID:18430249
RGD:2292908
NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294
G
Bambi
BMP and activin membrane-bound inhibitor
ISO
associated with stomach cancer; protein:increased expression: :
RGD
PMID:24752577
RGD:14390158
NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404
G
Barhl2
BarH like homeobox 2
ISO
associated with oral squamous cell carcinoma; mRNA:decreased expression:mouth mucous
RGD
PMID:27542258
RGD:14390167
NCBI chr 5:106,600,389...106,606,032
Ensembl chr 5:106,600,389...106,606,032
G
Bcl2
B cell leukemia/lymphoma 2
ISO
associated with Breast Neoplasms;protein:increased expression:lymph node
RGD
PMID:18217456
RGD:2293013
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bik
BCL2-interacting killer
ISO
associated with cholangiocarcinoma;DNA:CNV::
RGD
PMID:16865775
RGD:14394820
NCBI chr15:83,410,992...83,428,836
Ensembl chr15:83,411,063...83,428,835
G
Birc5
baculoviral IAP repeat-containing 5
disease_progression
ISO
associated with Cervix Neoplasms;mRNA:splice variant associated with Breast Neoplasms
RGD
PMID:17877643 PMID:17285241
RGD:2293098 , RGD:2293103
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Braf
Braf transforming gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29426936
NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
G
Brd7
bromodomain containing 7
severity
ISO
protein:increased expression:lung:
RGD
PMID:22008115
RGD:9586442
NCBI chr 8:89,056,522...89,089,249
Ensembl chr 8:89,057,667...89,088,822
G
Bsg
basigin
disease_progression
ISO
associated with Breast Neoplasms
RGD
PMID:16004819
RGD:2289055
NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803
G
Btk
Bruton agammaglobulinemia tyrosine kinase
disease_progression
ISO
associated with lung adenocarcinoma;protein:increased expression:lung (human)
RGD
PMID:31200752
RGD:151347847
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
G
Cab39
calcium binding protein 39
ISO
associated with pancreatic cancer;RNA:increased expression:pancreas
RGD
PMID:28197410
RGD:14398834
NCBI chr 1:85,707,796...85,779,298
Ensembl chr 1:85,721,162...85,779,297
G
Car9
carbonic anhydrase 9
ISO
associated with Cervix Neoplasms
RGD
PMID:17233814
RGD:2293196
NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729
G
Casp9
caspase 9
ISO
associated with Carcinoma, Non-Small-Cell Lung;DNA:SNP:exon:rs1052576 (human)
RGD
PMID:17285546
RGD:13434907
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cav1
caveolin 1, caveolae protein
disease_progression
ISO
associated with Melanoma
RGD
PMID:22134245
RGD:8661767
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Cbl
Casitas B-lineage lymphoma
ISO
associated with stomach carcinoma;protein:increased expression:stomach
RGD
PMID:31611438
RGD:126925223
NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346
G
Cblb
Casitas B-lineage lymphoma b
ISO
associated with stomach carcinoma;
RGD
PMID:20038312
RGD:150540338
NCBI chr16:51,851,593...52,028,410
Ensembl chr16:51,851,588...52,028,411
G
Ccnd2
cyclin D2
ISO
associated with colorectal cancer;protein:increased expression:colorectum
RGD
PMID:19508551
RGD:151665111
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
G
Ccne1
cyclin E1
ISO
associated with Carcinoma, Transitional Cell;protein:decreased expression
RGD
PMID:16949911
RGD:2289266
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
G
Ccnh
cyclin H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr13:85,337,504...85,361,850
Ensembl chr13:85,337,527...85,371,588
G
Ccr5
C-C motif chemokine receptor 5
ISO
associated with Breast Neoplasms;mRNA:increased expression:lymph node
RGD
PMID:24301790
RGD:8551816
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
G
Cd274
CD274 antigen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16530813
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
G
Cd40
CD40 antigen
ISO
associated with breast cancer;DNA:snps:5' utr, intron:c.-1T>C, c.51+914T>G (rs1883832, rs4810485) (human)
RGD
PMID:21912605
RGD:8547780
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd44
CD44 antigen
ISO
associated with Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms;mRNA, protein:splice variant, increased expression:breast, large intestine, stomach
RGD
PMID:16425351
RGD:2289356
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
G
Cdh1
cadherin 1
ISO
associated with Cervix Neoplasms associated with Breast Neoplasms
RGD
PMID:18097581 PMID:17649807
RGD:2296046 , RGD:2289498
NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
associated with Eyelid Neoplasms; associated with Oral Squamous Cell Carcinoma;
RGD
PMID:19628749 PMID:15817070
RGD:8661799 , RGD:8662374
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
ISO
associated with Breast Neoplasms associated with non-small cell lung carcinoma
RGD
PMID:12015771 PMID:28601655
RGD:2293607 , RGD:13673921
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Cdkn2a
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29426936
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
Cldn1
claudin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33665778
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
G
Clptm1l
CLPTM1-like
ISO
associated with esophagus squamous cell carcinoma; mRNA:increased expression:esophagus
RGD
PMID:25480402
RGD:150530497
NCBI chr13:73,752,121...73,768,758
Ensembl chr13:73,752,125...73,768,724
G
Clu
clusterin
ISO
associated with breast cancer;DNA:snp:promoter:g.27611345C>G (rs9331888) (human)
RGD
PMID:22037783
RGD:8963167
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Comt
catechol-O-methyltransferase
ISO
associated with breast cancer;DNA:missense mutation:cds:p.V108/158M (human)
RGD
PMID:10755383
RGD:8662330
NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602
G
Crp
C-reactive protein, pentraxin-related
susceptibility
ISO
associated with Breast Neoplasm; DNA:polymorphism: :1846C>T(rs1205)(human)
RGD
PMID:24633920
RGD:9580226
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf1r
colony stimulating factor 1 receptor
ISO
associated with Breast Neoplasms
RGD
PMID:14734466
RGD:2293711
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
IMP
associated with Prostatic Neoplasms
RGD
PMID:10611340
RGD:4891523
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Ctnna1
catenin alpha 1
ISO
associated with Breast Neoplasms
RGD
PMID:12047765
RGD:2289795
NCBI chr18:35,251,955...35,387,829
Ensembl chr18:35,251,912...35,387,832
G
Ctnnb1
catenin beta 1
ISO
associated with Breast Neoplasms;protein:decreased expression
RGD
PMID:17908479
RGD:2289813
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Cxcl12
C-X-C motif chemokine ligand 12
disease_progression
ISO
associated with stomach cancer;mRNA:increased expression:stomach (human)
RGD
PMID:21633638
RGD:152023624
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cxcr4
C-X-C motif chemokine receptor 4
ISO
associated with nasopharynx carcinoma; protein:increased expression:lymph node (human)
RGD
PMID:16000558
RGD:151893515
NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030
G
Cycs
cytochrome c, somatic
ISO
associated with non-small cell lung carcinoma; protein:decreased expression:serum
RGD
PMID:25578497
RGD:13792769
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
G
Ddr1
discoidin domain receptor family, member 1
severity
ISO
mRNA, protein:increased expression:mouth (human) mRNA:increased expression:kidney, lymph nodes (human)
RGD
PMID:31253192 PMID:27020590
RGD:151347620 , RGD:151347863
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
G
Ddr2
discoidin domain receptor family, member 2
disease_progression
ISO
associated with oral squamous cell carcinoma
RGD
PMID:29945346
RGD:150429700
NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
G
Dnmt3b
DNA methyltransferase 3B
ISO
associated with Carcinoma, Pancreatic Ductal;
RGD
PMID:22919364
RGD:9589121
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
Ebag9
estrogen receptor-binding fragment-associated gene 9
ISO
associated with Prostatic Neoplasm;protein:increased expression:prostate gland, lymph node associated with Breast Neoplasms;protein:increased expression:breast
RGD
PMID:12845666 PMID:17187007 PMID:12054692
RGD:2289856 , RGD:2289847 , RGD:2298489
NCBI chr15:44,482,574...44,504,916
Ensembl chr15:44,482,571...44,504,911
G
Egfr
epidermal growth factor receptor
treatment
IMP
associated with Squamous Cell Carcinoma of the Tongue
RGD
PMID:19380367
RGD:8551769
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Ehmt2
euchromatic histone lysine N-methyltransferase 2
ISO
associated with Melanoma; associated with Esophageal Squamous Cell Carcinoma;
RGD
PMID:24658378 PMID:24805087
RGD:9590069 , RGD:9590071
NCBI chr17:35,117,427...35,133,049
Ensembl chr17:35,117,445...35,133,028
G
Epha2
Eph receptor A2
ISO
protein:increased expression:esophagus (human)
RGD
PMID:33833989
RGD:153344568
NCBI chr 4:141,028,532...141,056,695
Ensembl chr 4:141,028,551...141,056,695
G
Erbb2
erb-b2 receptor tyrosine kinase 2
disease_progression
ISO
associated with Breast Neoplasms;DNA, protein:polymorphism, increased expression:serum:p.I655V associated with Carcinoma, Transitional Cell;protein:increased expression:urinary bladder CTD Direct Evidence: marker/mechanism associated with lung adenocarcinoma; protein:increased expression:lung (human)
CTD RGD
PMID:21532492 PMID:21966491 PMID:18237248 PMID:18097576
RGD:153344600 , RGD:2289925 , RGD:2289926
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
associated with Prostatic Neoplasms;protein:increased expression, altered localization:lymph node, nucleus associated with head and neck squamous cell carcinoma
RGD
PMID:17634423 PMID:20604875
RGD:2289944 , RGD:126790467
NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521
G
Erbb4
erb-b2 receptor tyrosine kinase 4
severity disease_progression
ISO
associated with oral squamous cell carcinoma associated with colorectal adenocarcinoma associated with lung non-small cell carcinoma
RGD
PMID:27444519 PMID:16507107 PMID:21324275
RGD:126781762 , RGD:126781766 , RGD:126790471
NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
G
Fas
Fas cell surface death receptor
susceptibility
ISO
associated with Cervix Neoplasms;DNA:polymorphism:promoter:-1377G>A
RGD
PMID:18068525
RGD:2298509
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fgf1
fibroblast growth factor 1
ISO
associated with Cervix Neoplasms;mRNA:increased expression:lymph node
RGD
PMID:17242701
RGD:2290286
NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525
G
Fgfr2
fibroblast growth factor receptor 2
ISO
associated with breast cancer;DNA:snp:intron:c.109+7033T>A (rs1219648) (human)
RGD
PMID:20640597
RGD:7394846
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
G
Flt3
FMS-like tyrosine kinase 3
disease_progression
IMP
associated with Prostatic Neoplasms
RGD
PMID:14566827
RGD:2302210
NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299
G
Foxa1
forkhead box A1
ISO
associated with lung non-small cell carcinoma; mRNA:increased expression: :
RGD
PMID:29115441
RGD:151665751
NCBI chr12:57,585,750...57,594,815
Ensembl chr12:57,587,414...57,593,702
G
Foxp1
forkhead box P1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25485836
NCBI chr 6:98,902,303...99,510,587
Ensembl chr 6:98,902,299...99,499,682
G
Gpx3
glutathione peroxidase 3
ISO
associated with stomach carcinoma; DNA:hypermethylation:promoter
RGD
PMID:23071548
RGD:151665353
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Grik2
glutamate receptor, ionotropic, kainate 2 (beta 2)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr10:48,969,776...49,666,523
Ensembl chr10:48,970,929...49,664,862
G
Hmgb1
high mobility group box 1
ISO
associated with Adenocarcinoma, Colon
RGD
PMID:20616616
RGD:10402080
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Icam1
intercellular adhesion molecule 1
ISO
associated with Breast Neoplasms
RGD
PMID:21590495
RGD:8547712
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ier2
immediate early response 2
ISO
RGD
PMID:22120713
RGD:153323322
NCBI chr 8:85,387,960...85,389,481
Ensembl chr 8:85,387,960...85,389,483
G
Il13
interleukin 13
ISO
associated with Melanoma, Cutaneous Malignant;mRNA:increased expression:lymph node
RGD
PMID:17545514
RGD:8549587
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il18
interleukin 18
ISO
associated with Breast Neoplasms;protein:increased expression:serum
RGD
PMID:12902898
RGD:8655867
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Ing4
inhibitor of growth family, member 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:27806345
NCBI chr 6:125,016,811...125,026,228
Ensembl chr 6:125,016,723...125,026,228
G
Iqsec1
IQ motif and Sec7 domain 1
disease_progression
ISO
associated with lung adenocarcinoma; protein:increased expression:lung (human)
RGD
PMID:21966491
RGD:153344600
NCBI chr 6:90,636,578...90,965,766
Ensembl chr 6:90,633,070...90,965,667
G
Itgb1
integrin beta 1 (fibronectin receptor beta)
ISO
associated with non-small cell lung carcinoma,
RGD
PMID:28537888
RGD:13792830
NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
G
Kcnj12
potassium inwardly-rectifying channel, subfamily J, member 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34755307
NCBI chr11:60,912,970...60,964,095
Ensembl chr11:60,913,390...60,961,957
G
Kdr
kinase insert domain protein receptor
treatment
IMP
associated with Squamous Cell Carcinoma of the Tongue
RGD
PMID:19380367
RGD:8551769
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Kiss1
KiSS-1 metastasis-suppressor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21383688
NCBI chr 1:133,249,625...133,257,460
Ensembl chr 1:133,237,565...133,257,460 Ensembl chr 1:133,237,565...133,257,460
G
Klf7
Kruppel-like transcription factor 7 (ubiquitous)
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:37734194
NCBI chr 1:64,068,607...64,161,504
Ensembl chr 1:64,068,606...64,161,441
G
Kmt2d
lysine (K)-specific methyltransferase 2D
ISO
associated with stomach cancer
RGD
PMID:30177394
RGD:150521710
NCBI chr15:98,729,550...98,771,958
Ensembl chr15:98,729,550...98,769,085
G
Lamc2
laminin, gamma 2
ISO
associated with lung squamous cell carcinoma;
RGD
PMID:23124251
RGD:13793371
NCBI chr 1:152,998,502...153,062,193
Ensembl chr 1:152,998,502...153,062,193
G
Lrrc59
leucine rich repeat containing 59
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr11:94,520,603...94,536,049
Ensembl chr11:94,520,593...94,536,042
G
Macir
macrophage immunometabolism regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 1:97,571,627...97,589,743
Ensembl chr 1:97,534,043...97,589,799
G
Met
met proto-oncogene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29426936
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Mir125a
microRNA 125a
ISO
associated with stomach cancer;
RGD
PMID:22322911
RGD:21408544
NCBI chr17:18,051,074...18,051,141
Ensembl chr17:18,051,074...18,051,141
G
Mir152
microRNA 152
ISO
associated with breast cancer
RGD
PMID:22935141
RGD:19165152
NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291
G
Mir155
microRNA 155
disease_progression
ISO
associated with colon cancer
RGD
PMID:26885061 PMID:27856635 PMID:29893326
RGD:21079444 , RGD:21079446 , RGD:21409756
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir187
microRNA 187
ISO
associated with oral squamous cell carcinoma; RNA:increased expression:plasma
RGD
PMID:27542258
RGD:14390167
NCBI chr18:24,562,167...24,562,227
Ensembl chr18:24,562,167...24,562,227
G
Mir224
microRNA 224
ISO
associated with colorectal cancer; mRNA:decreased expression:colorectal mucosa:
RGD
PMID:25919696
RGD:14398749
NCBI chr X:71,304,637...71,304,718
Ensembl chr X:71,304,637...71,304,718
G
Mir30a
microRNA 30a
ISO
associated with Colorectal Neoplasms
RGD
PMID:23486085
RGD:13432035
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mir335
microRNA 335
ISO
associated with stomach cancer; RNA:decreased expression:stomach
RGD
PMID:21822301
RGD:14394425
NCBI chr 6:30,741,298...30,741,395
Ensembl chr 6:30,741,298...30,741,395
G
Mir432
microRNA 432
disease_progression
ISO
mRNA:decreased expression:colon (human)
RGD
PMID:33717244
RGD:152999433
NCBI chr12:109,561,390...109,561,464
Ensembl chr12:109,561,390...109,561,464
G
Mmp2
matrix metallopeptidase 2
disease_progression
ISO
associated with Tongue Neoplasms associated with Carcinoma, Ductal, Breast
RGD
PMID:23107277 PMID:23280016
RGD:8547824 , RGD:8655998
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp3
matrix metallopeptidase 3
ISO
associated with breast cancer;DNA:deletion:promoter:-1170_-1172delA (human)
RGD
PMID:15161710
RGD:8662937
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mmp9
matrix metallopeptidase 9
disease_progression
ISO
associated with Carcinoma, Non-Small-Cell Lung;protein:increased expression:serum associated with Endometrial Neoplasms;protein:increased expression:endometrium associated with Tongue Neoplasms
RGD
PMID:20704821 PMID:12487935 PMID:23107277
RGD:5129215 , RGD:2298523 , RGD:8547824
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Msh2
mutS homolog 2
ISO
associated with laryngeal squamous cell carcinoma
RGD
PMID:24459922
RGD:126848797
NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141
G
Msln
mesothelin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22644300
NCBI chr17:25,967,587...25,973,352
Ensembl chr17:25,967,587...25,973,352
G
Mta1
metastasis associated 1
ISO
associated with Carcinoma, Non-Small-Cell Lung;mRNA:increased expression:lung
RGD
PMID:11804687
RGD:9588220
NCBI chr12:113,061,830...113,100,826
Ensembl chr12:113,061,898...113,100,826
G
Mtor
mechanistic target of rapamycin kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Muc1
mucin 1, transmembrane
ISO
associated with Common Bile Duct Neoplasms associated with Gallbladder Neoplasms;protein:altered localization:gallbladder associated with Carcinoma, Renal Cell; associated with Esophageal Neoplasms
RGD
PMID:16222735 PMID:11295067 PMID:10390012 PMID:21339746
RGD:2324649 , RGD:2324860 , RGD:7245968 , RGD:7349383
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
ISO
associated with chloangiocarcinoma;protein:increased expression:bile duct
RGD
PMID:16842244
RGD:2325168
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
G
Ncam1
neural cell adhesion molecule 1
IMP
RGD
PMID:10086383
RGD:2326067
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
ISO
associated with Cervix Neoplasms; associated with Endometrial Neoplasms associated with Breast Neoplasms
RGD
PMID:8855975 PMID:9036878 PMID:8102131
RGD:2299062 , RGD:2299061 , RGD:2299077
NCBI chr11:93,849,751...93,859,341
Ensembl chr11:93,847,805...93,859,347
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
ISO
associated with Cervix Neoplasms; associated with Endometrial Neoplasms
RGD
PMID:8855975
RGD:2299062
NCBI chr11:93,840,640...93,847,082
Ensembl chr11:93,840,640...93,847,085
G
Nos3
nitric oxide synthase 3, endothelial cell
susceptibility
ISO
associated with Breast Neoplasms;DNA:polymorphisms:promoter, exon:-786T>C,p.E298D (human)
RGD
PMID:17262178
RGD:2292070
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Ogg1
8-oxoguanine DNA-glycosylase 1
ISO
associated with breast cancer;DNA:missense mutation:cds:p.S326C (rs1052133) (human)
RGD
PMID:18977234
RGD:8657156
NCBI chr 6:113,303,959...113,311,149
Ensembl chr 6:113,303,933...113,312,029
G
Pagr1a
PAXIP1 associated glutamate rich protein 1A
disease_progression
ISO
protein:decreased expression:esophagus (human)
RGD
PMID:33833989
RGD:153344568
NCBI chr 7:126,614,223...126,616,524
Ensembl chr 7:126,614,205...126,616,524 Ensembl chr 7:126,614,205...126,616,524
G
Pdgfa
platelet derived growth factor, alpha
ISO
associated with Breast Neoplasms;mRNA:increased expression:breast
RGD
PMID:8619189
RGD:2292155
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfb
platelet derived growth factor, B polypeptide
ISO
associated with Breast Neoplasms;mRNA:increased expression:lymph node
RGD
PMID:17674348
RGD:2292173
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdpk1
3-phosphoinositide dependent protein kinase 1
ISO
associated with non-small cell lung carcinoma;mRNA:increased expression:blood serum
RGD
PMID:25064732
RGD:13503320
NCBI chr17:24,292,654...24,370,957
Ensembl chr17:24,292,654...24,369,898
G
Pdpn
podoplanin
ISO
associated with Breast Neoplasms associated with Cervix Neoplasms
RGD
PMID:18165897 PMID:16528371
RGD:2292231 , RGD:2292237
NCBI chr 4:142,993,979...143,026,134
Ensembl chr 4:142,994,001...143,026,134
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
associated with Breast Neoplasms associated with Cervix Neoplasms
RGD
PMID:16243812 PMID:18191186
RGD:2302868 , RGD:2302867
NCBI chr 5:117,420,716...117,425,629
Ensembl chr 5:117,420,719...117,425,690
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
ISO
associated with Colorectal Neoplasms
RGD
PMID:25550888
RGD:13432030
NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
ISO
associated with Colorectal Neoplasms
RGD
PMID:25550888
RGD:13432030
NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674
G
Pip5k1a
phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34755307
NCBI chr 3:94,965,841...95,014,241
Ensembl chr 3:94,965,841...95,014,241
G
Pou5f1
POU domain, class 5, transcription factor 1
ISO
associated with Seminoma; associated with Carcinoma, Embryonal
RGD
PMID:15386301
RGD:2292442
NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
associated with Cholangiocarcinoma;protein:increased expression:bile duct epithelium
RGD
PMID:20021832
RGD:2317459
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Prex1
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
ISO
associated with Prostatic Neoplasms
RGD
PMID:19305425
RGD:2314605
NCBI chr 2:166,408,265...166,555,752
Ensembl chr 2:166,408,262...166,555,752
G
Pten
phosphatase and tensin homolog
ISO
associated with Prostatic Neoplasms;protein:decreased expression:prostate associated with Breast Neoplasms
RGD
PMID:17163422 PMID:17919877
RGD:2292507 , RGD:2292499
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
associated with Biliary Tract Neoplasms associated with Breast Neoplasms associated with carcinoma, non-small-cell lung; DNA:SNP: :929G>C(human)
RGD
PMID:18159174 PMID:18353210 PMID:20016751
RGD:2317165 , RGD:2300128 , RGD:5135471
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptk2
PTK2 protein tyrosine kinase 2
ISO
associated with lung squamous cell carcinoma; protein:increased tyrosine phosphorylation:lymph node
RGD
PMID:23906871
RGD:152176664
NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129
G
Ptpn13
protein tyrosine phosphatase, non-receptor type 13
ISO
associated with lung squamous cell carcinoma; protein:decreased expression:lymph node
RGD
PMID:23906871
RGD:152176664
NCBI chr 5:103,573,058...103,746,227
Ensembl chr 5:103,573,058...103,746,169
G
Ramp2
receptor (calcitonin) activity modifying protein 2
disease_progression
ISO
associated with colorectal cancer; protein:increased expression:lymph node (human)
RGD
PMID:23634287
RGD:151708733
NCBI chr11:101,137,160...101,139,076
Ensembl chr11:101,136,854...101,150,372
G
Ramp3
receptor (calcitonin) activity modifying protein 3
ISO
associated with colorectal cancer; protein:increased expression:lymph node (human)
RGD
PMID:23634287
RGD:151708733
NCBI chr11:6,608,507...6,627,478
Ensembl chr11:6,608,521...6,627,475
G
Rassf2
Ras association (RalGDS/AF-6) domain family member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17013896
NCBI chr 2:131,834,770...131,872,336
Ensembl chr 2:131,831,335...131,872,178
G
Rbm10
RNA binding motif protein 10
ISO
associated with lung adenocarcinoma;DNA:missense mutation:exon:p.R241C (c.763C>T) (human)
RGD
PMID:30405763
RGD:151356993
NCBI chr X:20,483,596...20,517,128
Ensembl chr X:20,483,742...20,517,140
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
associated with Prostatic Neoplasms;protein:altered localization:nucleus, prostate gland
RGD
PMID:17020979
RGD:2298757
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Ret
ret proto-oncogene
ISO
associated with Pancreatic Neoplasms
RGD
PMID:18652760
RGD:2324925
NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679
G
Rhoa
ras homolog family member A
ISO
associated with Bladder Neoplasms;protein:increased expression:lymph node associated with colorectal cancer
RGD
PMID:12855641 PMID:17597401
RGD:2298872 , RGD:13432052
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Rictor
RPTOR independent companion of MTOR, complex 2
ISO
associated with breast ductal carcinoma; protein:increased expression:breast tumor, lymph node (human)
RGD
PMID:20978191
RGD:152995469
NCBI chr15:6,737,827...6,829,882
Ensembl chr15:6,737,860...6,829,882
G
Runx1
runt related transcription factor 1
ISO
associated with Carcinoid Tumor
RGD
PMID:21636701
RGD:126779567
NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037
G
Sfn
stratifin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19381893
NCBI chr 4:133,327,867...133,329,163
Ensembl chr 4:133,327,867...133,329,479
G
Skp2
S-phase kinase-associated protein 2
ISO
associated with Endometrial Neoplasms;protein:increased expression:endometrium
RGD
PMID:16080017
RGD:2315043
NCBI chr15:9,112,070...9,155,512
Ensembl chr15:9,112,073...9,155,512
G
Slc7a5
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5
severity
ISO
associated with stomach carcinoma associated with gastric adenocarcinoma;protein:increased expression: :
RGD
PMID:25908107 PMID:21501294
RGD:11052781 , RGD:151361203
NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
G
Smad4
SMAD family member 4
ISO
associated with Breast Neoplasms
RGD
PMID:11809701
RGD:2300007
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
G
Smo
smoothened, frizzled class receptor
ISO
associated with colorectal cancer
RGD
PMID:30784110
RGD:150520177
NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
G
Sncg
synuclein, gamma
ISO
RGD
PMID:15221989
RGD:6478801
NCBI chr14:34,092,231...34,096,626
Ensembl chr14:34,092,231...34,096,746
G
Socs2
suppressor of cytokine signaling 2
ISO
associated with Prostatic Neoplasms
RGD
PMID:16707422
RGD:2298925
NCBI chr10:95,219,765...95,253,176
Ensembl chr10:95,221,224...95,253,042
G
Socs3
suppressor of cytokine signaling 3
ISO
associated with Breast Neoplasms
RGD
PMID:18097573
RGD:2298901
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Sod2
superoxide dismutase 2, mitochondrial
disease_progression
ISO
associated with tongue neoplasms; CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10853026 PMID:19381893 PMID:20618948 PMID:20618948
RGD:8547519
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sox2
SRY (sex determining region Y)-box 2
disease_progression
ISO
associated with Breast Neoplasms
RGD
PMID:24382260
RGD:8661670
NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
G
Src
Rous sarcoma oncogene
ISO
associated with colon adenocarcinoma,
RGD
PMID:21282564
RGD:150520218
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
G
St14
suppression of tumorigenicity 14 (colon carcinoma)
ISO
associated with Endometrial Neoplasms
RGD
PMID:19443387
RGD:2315087
NCBI chr 9:30,999,886...31,043,138
Ensembl chr 9:31,000,698...31,043,149
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21549414
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Stk11
serine/threonine kinase 11
ISO
associated with Breast Neoplasms;protein:decreased expression
RGD
PMID:12114407
RGD:2291948
NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516
G
Tert
telomerase reverse transcriptase
disease_progression
ISO
associated with lung non-small cell carcinoma;
RGD
PMID:11679180
RGD:152977755
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Timp1
tissue inhibitor of metalloproteinase 1
ISO
associated with Endometrial Neoplasms;protein:increased expression:endometrium
RGD
PMID:12487935
RGD:2298523
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Timp3
tissue inhibitor of metalloproteinase 3
ISO
associated with Breast Neoplasms;mRNA:increased expression:breast
RGD
PMID:12828172
RGD:2290437
NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
G
Timp4
tissue inhibitor of metalloproteinase 4
ISO
associated with Breast Neoplasms;mRNA:increased expression:breast
RGD
PMID:12828172
RGD:2290437
NCBI chr 6:115,221,405...115,229,166
Ensembl chr 6:115,218,853...115,229,166
G
Tlr4
toll-like receptor 4
ISO
associated with Carcinoma, Ductal, Breast;
RGD
PMID:23338716
RGD:7794684
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Trmt11
tRNA methyltransferase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr10:30,410,218...30,477,598
Ensembl chr10:30,410,221...30,476,745
G
Trp53
transformation related protein 53
ISO IMP
associated with Penile Neoplasms associated with Breast Neoplasms;DNA:missense mutation, duplication:cds, intron:p.R72P associated with Carcinoma, Squamous Cell;
RGD
PMID:18268397 PMID:18230179 PMID:18059331
RGD:2290533 , RGD:2290534 , RGD:8547790
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trp53bp1
transformation related protein 53 binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30705370
NCBI chr 2:121,025,316...121,126,830
Ensembl chr 2:121,023,762...121,101,888
G
Tsc2
TSC complex subunit 2
ISO
associated with Breast Neoplasms
RGD
PMID:15951164
RGD:11568707
NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604
G
Tshr
thyroid stimulating hormone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9062474
NCBI chr12:91,367,767...91,507,283
Ensembl chr12:91,351,337...91,516,582
G
Ttr
transthyretin
ISO
associated with colorectal cancer;protein:decreased expresion:blood serum (human)
RGD
PMID:21074777
RGD:151665155
NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378
G
Tymp
thymidine phosphorylase
ISO
associated with Cholangiocarcinoma associated with Breast Neoplasms
RGD
PMID:11927969 PMID:10685502
RGD:2325027 , RGD:2293725
NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242
G
Vegfa
vascular endothelial growth factor A
ISO IMP
associated with Cervix Neoplasms associated with Breast neoplasms;
RGD
PMID:19783962 PMID:17597103
RGD:2315454 , RGD:7421574
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vegfc
vascular endothelial growth factor C
disease_progression exacerbates
ISO
associated with Carcinoma, Transitional Cell;protein:increased expression:urinary bladder associated with Cervix Neoplasms associated with Prostatic Neoplasms associated with Breast Neoplasms associated with thyroid diseases;mRNA:increased expression:thyroid gland: associated with Lymphatic Metastasis; associated with pancreatic adenocarcinoma;protein:increased expression:pancreas (human)
RGD
PMID:17034609 PMID:19589137 PMID:19608016 PMID:19923084 PMID:12203051 PMID:15289890 PMID:18061373 More...
RGD:2315484 , RGD:2315475 , RGD:2315474 , RGD:2315469 , RGD:7483611 , RGD:7488946 , RGD:155630642
NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
G
Vegfd
vascular endothelial growth factor D
ISO
associated with Cervix Neoplasms associated with Breast Neoplasms
RGD
PMID:19589137 PMID:17951197
RGD:2315475 , RGD:2315480
NCBI chr X:163,156,282...163,185,643
Ensembl chr X:163,156,374...163,185,646
G
Wrap53
WD repeat containing, antisense to Trp53
ISO
associated with lung non-small cell carcinoma; associated with esophagus squamous cell carcinoma;
RGD
PMID:31281482 PMID:24626331
RGD:21081513 , RGD:21081532
NCBI chr11:69,452,580...69,471,076
Ensembl chr11:69,452,584...69,471,081
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all